# Alexion Pharmaceuticals, Inc. – FDA Inspection, Apr 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/e46b5300-bd31-4ab3-a7d2-fb7b1c1f27e8
Source feed: FDA_Inspections

> FDA inspection 1010567 of Alexion Pharmaceuticals, Inc., April 25, 2017. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010567
- Company Name: Alexion Pharmaceuticals, Inc.
- Inspection Date: 2017-04-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 919566 - 2015-01-21

## Related Officers

- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/2c0ca8b5-cf21-4cfb-b33e-6cf8b519ec74

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
